Published in Gene Therapy Weekly, August 9th, 1999
J. Kim and colleagues from the Samsung Biomedical Research Institute, South Korea, investigated a combination therapy approach to ovarian cancer ("Intraperitoneal Gene Therapy with Adenoviral-Mediated p53 Tumor Suppressor Gene for Ovarian Cancer Model in Nude Mouse," Cancer Gene Therapy, 1999;6(2):172-178).
"In an effort to develop a method for better local control of advanced ovarian cancers, we have established a peritoneal tumor model of ovarian cancer in the nude mouse and applied intraperitoneal gene therapy with the recombinant adenoviral-mediated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.